Author Correction: The randomized ZIPANGU trial of ranibizumab and adjunct laser for macular edema following branch retinal vein occlusion in treatment‑naïve patients

Affiliations

• ¹ Department of Ophthalmology, Shinshu University School of Medicine, 3‑1‑1 Asahi, Matsumoto, Nagano, Japan. murata@shinshu-u.ac.jp.
• ² Department of Ophthalmology, Mie University Graduate School of Medicine, Mie, Japan.
• ³ Department of Ophthalmology, Kyorin Eye Center, Kyorin University School of Medicine, Tokyo, Japan.
• ⁴ Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
• ⁵ Department of Ophthalmology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
• ⁶ Department of Ophthalmology, Asahikawa Medical University, Hokkaido, Japan.
• ⁷ Novartis Pharma K.K., Tokyo, Japan.
• ⁸ Novartis Healthcare Pvt. Ltd., Hyderabad, India.
• ⁹ Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
• ¹⁰ Department of Ophthalmology, Aichi Medical University, Aichi, Japan.